BACR Gordon Hamilton-Fairley Young Investigator Award
BACR1 – BACR10
- BACR1: Homotypic adhesion and lysosome-mediated cell death evoked by anti-CD20 (Tositumomab) and HLA DR monoclonal antibodies
- BACR2: Chronic but not acute hypoxia exposure impairs replication restart after reoxygenation via replisome disassembly
- BACR3: The regulation of desmosomal cadherins in epithelial-mesenchymal transition
- BACR4: Expression of embryonic stem cell markers, OCT4 and NANOG, in breast, thyroid, brain and colorectal carcinomas
- BACR5: A segmentation algorithm for quantitative morphological analysis of microvessels in immunostained histological tumour sections
- BACR6: The mechanisms and consequences of p53 inactivation in laryngeal squamous cell carcinoma
- BACR7: Altered expression of thioredoxin system proteins, in locally advanced breast cancer, predicts response to anthracyclin based chemotherapy
- BACR8: Prevalence of cancer stem cells and its association with clinical outcome and prognostic factors in breast cancer patients
- BACR9: Physicochemical and pharmacological determinants of the efficacy of a novel series of CDK7 inhibitors
- BACR10: Development of [18F]Fluoro-[1,2-2H4]choline as a new PET imaging probe
